Paracrine Fibroblast Growth Factor Initiates Oncogenic Synergy with Epithelial FGFR/Src Transformation in Prostate Tumor Progression

Paracrine Fibroblast Growth Factor Initiates Oncogenic Synergy with Epithelial FGFR/Src Transformation in Prostate Tumor Progression

Cross talk of stromal-epithelial cells plays an essential role in both normal development and tumor initiation and progression. Fibroblast growth factor (FGF)-FGF receptor (FGFR)-Src kinase axis is one of the major signal transduction pathways to mediate this cross talk. Numerous genomic studies hav...

Full description

Bibliographic Details
Main Authors:	Qianjin Li, Lishann Ingram, Sungjin Kim, Zanna Beharry, Jonathan A. Cooper, Houjian Cai
Format:	Article
Language:	English
Published:	Elsevier 2018-03-01
Series:	Neoplasia: An International Journal for Oncology Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1476558617305055

Similar Items

Paracrine effect of TAK1 in fibroblasts on the oncogenic potential of adjacent epithelia.
by: Yeo, Ronne Wee Yeh.
Published: (2009)

CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition
by: Yongning Lu, et al.
Published: (2019-09-01)

Src family kinases engage differential pathways for encapsulation into extracellular vesicles
by: Chenming Ye, et al.
Published: (2023-06-01)

Paracrine interactions through FGFR1 and FGFR2 receptors regulate the development of preimplantation mouse chimaeric embryo
by: Katarzyna Krawczyk, et al.
Published: (2022-11-01)

Targeting the Src Pathway Enhances the Efficacy of Selective FGFR Inhibitors in Urothelial Cancers with FGFR3 Alterations
by: Nadia Carvalho Lima, et al.
Published: (2020-05-01)

Effects of androgen receptor and androgen on gene expression in prostate stromal fibroblasts and paracrine signaling to prostate cancer cells.
by: Matthew J Tanner, et al.
Published: (2011-01-01)

FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy
by: Álvaro Quintanal-Villalonga, et al.
Published: (2020-03-01)

Src is essential for the endosomal delivery of the FGFR4 signaling complex in hepatocellular carcinoma
by: Ji-Yon Shin, et al.
Published: (2021-04-01)

Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis
by: Jinglin Zhang, et al.
Published: (2019-06-01)

Intrinsic FGFR2 and Ectopic FGFR1 Signaling in the Prostate and Prostate Cancer
by: Cong Wang, et al.
Published: (2019-01-01)

Claudin-2 Mediates the Proximal Tubular Epithelial Cell–Fibroblast Crosstalk via Paracrine CTGF
by: Guo C, et al.
Published: (2024-01-01)

Chlamydial YAP activation in host endocervical epithelial cells mediates pro-fibrotic paracrine stimulation of fibroblasts
by: Liam Caven, et al.
Published: (2023-12-01)

Progesterone prevents HGSOC by promoting precancerous cell pyroptosis via inducing fibroblast paracrine
by: Nayiyuan Wu, et al.
Published: (2023-04-01)

Functional screen of paracrine signals in breast carcinoma fibroblasts.
by: Gui Su, et al.
Published: (2012-01-01)

Ephrin B Activate Src Family Kinases in Fibroblasts Inducing Stromal Remodeling in Prostate Cancer
by: Mamatha Kakarla, et al.
Published: (2022-05-01)

Cancer-associated fibroblasts induce epithelial–mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling
by: Cassandra Ringuette Goulet, et al.
Published: (2019-02-01)

Endocrine and paracrine characteristics of neuroendocrine prostate cancer
by: Tarana Arman, et al.
Published: (2022-11-01)

Correction: Functional Screen of Paracrine Signals in Breast Carcinoma Fibroblasts
Published: (2013-01-01)

Correction: Functional Screen of Paracrine Signals in Breast Carcinoma Fibroblasts.
by: Gui Su, et al.
Published: (2013-01-01)

Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
by: Zingg, D, et al.
Published: (2022)

Oncogenic activation revealed by FGFR2 genetic alterations in intrahepatic cholangiocarcinomas
by: Xiaohong Pu, et al.
Published: (2023-11-01)

Oncogenic FGFR Fusions Produce Centrosome and Cilia Defects by Ectopic Signaling
by: Alexandru Nita, et al.
Published: (2021-06-01)

The FGF/FGFR System in Breast Cancer: Oncogenic Features and Therapeutic Perspectives
by: Maria Francesca Santolla, et al.
Published: (2020-10-01)

L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling
by: Marco Giordano, et al.
Published: (2021-10-01)

FGFR blockade inhibits targeted therapy-tolerant persister in basal FGFR1- and FGF2-high cancers with driver oncogenes
by: Koh Furugaki, et al.
Published: (2023-10-01)

Regulation of Fibroblast Cell Polarity by Src Tyrosine Kinase
by: Kazuo Katoh
Published: (2021-02-01)

The Role of Fibroblasts in Pancreatic Cancer: Extracellular Matrix Versus Paracrine Factors
by: Louisa Bolm, et al.
Published: (2017-08-01)

The Differential Paracrine Role of the Endothelium in Prostate Cancer Cells
by: Verónica Torres-Estay, et al.
Published: (2022-09-01)

Derazantinib Inhibits the Bioactivity of Keloid Fibroblasts via FGFR Signaling
by: Shuqia Xu, et al.
Published: (2023-12-01)

Negative Regulation of FGFR (Fibroblast Growth Factor Receptor) Signaling
by: Patrycja Szybowska, et al.
Published: (2021-05-01)

Hyperglycemia activates FGFR1 via TLR4/c-Src pathway to induce inflammatory cardiomyopathy in diabetes
by: Xiong Chen, et al.
Published: (2024-04-01)

Rhenium N-heterocyclic carbene complexes block growth of aggressive cancers by inhibiting FGFR- and SRC-mediated signalling
by: Alice Domenichini, et al.
Published: (2020-12-01)

The proto-oncogene SRC phosphorylates cGAS to inhibit an antitumor immune response
by: William Dunker, et al.
Published: (2023-06-01)

Drosophila PRL-1 is a growth inhibitor that counteracts the function of the Src oncogene.
by: Krystle T Pagarigan, et al.
Published: (2013-01-01)

FGFR-2 and Epithelial–Mesenchymal Transition in Endometrial Cancer
by: Olga Adamczyk-Gruszka, et al.
Published: (2022-09-01)

Site-specific keloid fibroblasts alter the behaviour of normal skin and normal scar fibroblasts through paracrine signalling.
by: Kevin J Ashcroft, et al.
Published: (2013-01-01)

Src: marker or actor of prostate cancer aggressiveness
by: Virginie eVlaeminck-Guillem, et al.
Published: (2014-08-01)

The cyclooxygenase-expressing mesenchyme resists intestinal epithelial injury by paracrine signaling
by: Siting Wei, et al.
Published: (2023-08-01)

Targeting the Fibroblast Growth Factor Receptor (FGFR) Family in Lung Cancer
by: Laura Pacini, et al.
Published: (2021-05-01)

Methionine restriction breaks obligatory coupling of cell proliferation and death by an oncogene Src in Drosophila
by: Hiroshi Nishida, et al.
Published: (2021-04-01)